Continual reassessment method with multiple toxicity constraints
From MaRDI portal
Publication:3303685
DOI10.1093/BIOSTATISTICS/KXQ062zbMath1437.62521OpenAlexW2121660184WikidataQ33392065 ScholiaQ33392065MaRDI QIDQ3303685
Bin Cheng, Ying-Kuen Cheung, Shing M. Lee
Publication date: 4 August 2020
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/kxq062
Related Items (1)
Cites Work
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
- On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance
- A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method
- Coherence principles in dose-finding studies
- Risk-Group-Specific Dose Finding Based on an Average Toxicity Score
- Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose
- A Random Walk Rule for Phase I Clinical Trials
- Stochastic approximation with virtual observations for dose-finding on discrete levels
- The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach
- Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial
This page was built for publication: Continual reassessment method with multiple toxicity constraints